Order Entry
Switzerland
ContactUsLinkComponent
Human recombinant SLAMF7 (from HEK293)
Human recombinant SLAMF7 (from HEK293)
Supplier:  ACRO Biosystems
Certificates
Human recombinant SLAMF7 (from HEK293)
Supplier:  ACRO Biosystems

Specifications

  • Protein/peptide type:
    Recombinant
  • Sorgente luminosa:
    HEK293 cells
  • Specie:
    Human
  • Condizioni di conservazione:
    –20 °C
  • Contenuto di endotossine:
    Less than 1,0 EU per μg by the LAL method.
  • Attività biologica:
    Lyopilised from 0,22 μm filtered solution in PBS, pH 7,4. Normally trehalose is added as protectant before lyophilisation.; Measured by its binding ability in a functional ELISA. Immobilised Humanized Anti-Human CS1 MAb at 1 μg/ml (100 µl/well) can bind Biotinylated Human SLAMF7, Avitag,His Tag with a linear range of 0,6-5 ng/ml (Routinely tested).; 2e5 of Anti-SLAMF7 CAR-293 cells were stained with 100 µl of 0,1 μg/ml of Biotinylated Human SLAMF7, Avitag, His Tag and negative control protein respectively, washed and then followed by PE-SA and analyzed with FACS (QC tested).
  • ID gene:
    Q9NQ25-1
  • Senza corriere:
    Y
  • Protease-free:
    Y
  • Senza animali:
    Y
  • Protein synonyms:
    FOAP-12|CRACC|19A|CS1|CD319|SLAMF7
  • Protein/peptide name:
    SLAMF7
  • Purezza:
    >95%
  • Peso molecolare:
    25,6 kDa
  • Livello di endotossine:
    Low
  • Formulazione:
    Lyopilised from 0,22 μm filtered solution in PBS, pH 7,4. Normally trehalose is added as protectant before lyophilisation.
  • Esente da nucleasi:
    Y
  • Temperatura di spedizione:
    Powder,RT

Specifications

Frequently Bought Together